The NeurologyLive® Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.
November 22nd 2022
A panel of experts in neurology discuss comorbidities in multiple sclerosis and the use of sphingosine 1-phosphate receptor modulators for treatment. They discuss data on sequencing of disease modifying therapies and challenges and their approaches to guiding patients through treatment discontinuations.
October 12th 2022
An expert cardiologist, sleep specialist, and pulmonologist, share insights on the awareness and treatment of sleep disorders, including insomnia, that co-occur with other health conditions.
September 2nd 2022
Experts in neurology provide insight on neuromyelitis optica spectrum disorder (NMOSD) in racially and ethnically diverse patient populations, highlighting treatment considerations and engaging patients in clinical trial and therapeutic development.
June 30th 2022
Experts in neurology share considerations for the management of ethnically diverse and underrepresented populations including those of reproductive age who have the Epstein-Barr virus.
June 29th 2022
Experts in neurology discuss changes in cognitive health and the role of sphingosine-1-phospate receptor modulators and disease-modifying therapies play in multiple sclerosis management.
May 6th 2022
Expert neurologists discuss the impact of MS on the immune system and comment on the use of COVID-19 vaccines with MS treatment and the use of high efficacy therapies in MS.
May 5th 2022
Experts in movement disorders highlight the importance of patient and provider education around OFF episodes and share strategies for optimizing the management of OFF episodes in the Parkinson disease treatment landscape.
March 18th 2022
In this Peer Exchange special edition, Scott Newsome, DO, leads a discussion with Alberto Ascherio, MD, DrPH; Anne Cross, MD; Avindra Nath, MD; and Michael Racke, MD, about the practical and clinical implications of a recently published novel longitudinal study, the first of its kind to draw a causal link between Epstein-Barr Virus and multiple sclerosis.
January 18th 2022
Jessica Ailani, MD; Bradley Torphy, MD; Sait Ashina, MD; Andrew C. Charles, MD; and Julio R. Vieira, MD, share expert approaches to the diagnosis and treatment of acute and preventive migraine and discuss key insights on the evolving treatment landscape.